Skip to main content
logo
PreveCeutical Medical Inc. (CSE:PREV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0250
0.00 (0.00%)
Aug 28, 2026, 9:30 AM EST

PreveCeutical Medical Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
1.812.270.580.680.570.68
Research & Development
0.20.230.080.090.080.06
Amortization of Goodwill & Intangibles
0.020.010.010.010.010.01
Operating Expenses
2.183.240.750.921.040.83
Operating Income
-2.18-3.24-0.75-0.92-1.04-0.83
Interest Expense
-0.32-0.32-0.33-0.31-0.24-0.47
Interest & Investment Income
0.040.01----
Earnings From Equity Investments
-0.18-0.02----
Currency Exchange Gain (Loss)
-0.010-0.04-0-0-0.21
Other Non Operating Income (Expenses)
-0.12-0.13-0.06-0.05-0.06-0.06
EBT Excluding Unusual Items
-2.76-3.7-1.17-1.27-1.34-1.58
Gain (Loss) on Sale of Assets
2.012.01--0-0
Other Unusual Items
-----0.15-0.17
Pretax Income
-0.76-1.69-1.17-1.27-1.48-1.75
Income Tax Expense
------0.02
Earnings From Continuing Operations
-0.76-1.69-1.17-1.27-1.48-1.73
Minority Interest in Earnings
0.070.11----
Net Income
-0.69-1.58-1.17-1.27-1.48-1.73
Net Income to Common
-0.69-1.58-1.17-1.27-1.48-1.73
Net Income Growth
------
Shares Outstanding (Basic)
594569536535522508
Shares Outstanding (Diluted)
594569536535522508
Shares Change
9.11%6.13%0.15%2.59%2.72%11.43%
EPS (Basic)
-0.00-0.00-0.00-0.00-0.00-0.00
EPS (Diluted)
-0.00-0.00-0.00-0.00-0.00-0.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.6-1.72-0.43-0.3-0.22-0.43
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00--0.00
EBITDA
-2.16-3.23-0.74-0.91-1.03-0.83
D&A For EBITDA
0.020.010.010.010.010.01
EBIT
-2.18-3.24-0.75-0.92-1.04-0.83